The main purpose of this study is to evaluate the safety and efficacy of donanemab in participants with preclinical Alzheimer's Disease (AD).

A Donanemab (LY3002813) Prevention Study in Participants With Alzheimer's Disease (TRAILBLAZER-ALZ 3)

Birmingham, AL

Greensboro - Cardiology

Monroe, NC

Augusta, GA

Oxon Hill, MD

Media, PA

Tulsa, OK

East Syracuse, NY

Richmond Behavioral Associates

Ocala, FL

Winter Park, FL

Clearwater, FL

Tampa, FL

Beaumont, TX

Bradenton, FL

Waltham, MA

Methuen, MA

West Palm Beach, FL

Boca Raton, FL

Hollywood, FL

Pembroke Pines, FL

Miami Lakes, FL

Miami Springs, FL

Miami, FL

San Antonio, TX

Rapid City, SD

Denver, CO

Weslaco, TX

McAllen, TX

Basalt, CO

Albuquerque Neuroscience

Tucson, AZ

Redlands, CA

Riverside, CA

San Diego, CA

Covina, CA

Santa Ana, CA

Inspira Clinical Research

Irvine, CA

San Juan, PR

Huntington Beach, CA

Northridge, CA

Sacramento, CA

Bellevue, WA

Tacoma, WA

Tokyo, Japan

Lilly

Find clinical trials for Alzheimer's Disease in Louisville, KY

Related conditions:

Alzheimer's Disease trials near Louisville, KY, USA:

A Donanemab (LY3002813) Prevention Study in Participants With Alzheimer's Disease (TRAILBLAZER-ALZ 3)

Find clinical trials for Alzheimer's Disease in .css-epvm6{white-space:nowrap;}Louisville, KY

Related conditions:

Alzheimer's Disease trials near Louisville, KY, USA:

A Donanemab (LY3002813) Prevention Study in Participants With Alzheimer's Disease (TRAILBLAZER-ALZ 3)

Find clinical trials for Alzheimer's Disease in Louisville, KY